John Cochran
Director at Aquestive Therapeutics, Inc. (AQST)
John Cochran has filed 7 insider reports with the SEC since March 2021, as director at Aquestive Therapeutics, Inc. (AQST). The latest filing, on June 12, 2026, reports grant or award at Aquestive Therapeutics, Inc. (AQST).
- Filings
- 7
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where John Cochran is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 99,486 | $3.46 | Jun 12, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 10, 2026AQSTSEC Form 4 filed by Director Cochran JohnForm 4Grant or award
- Jun 11, 2025AQSTSEC Form 4 filed by Director Cochran JohnForm 4Grant or award
- Jun 20, 2024AQSTSEC Form 4 filed by Director Cochran JohnForm 4Grant or award
- Jun 21, 2023AQSTSEC Form 4 filed by Cochran JohnForm 4Grant or award
- Jun 22, 2022AQSTSEC Form 4 filed by Cochran JohnForm 4Grant or award
- Jun 15, 2021AQSTSEC Form 4 filed by Cochran JohnForm 4Grant or award
- Mar 12, 2021AQSTSEC Form 4: John Cochran increased direct ownership by 82% to 136,986 unitsForm 4Other acquisition or disposition
Compare John Cochran with
- John Cochran vs Matthew W. Davis1 shared
- John Cochran vs Richard J Daly1 shared
- John Cochran vs Daniel Barber1 shared
- John Cochran vs Sherry Korczynski1 shared
- John Cochran vs Peter E. Boyd1 shared
- John Cochran vs Cassie Jung1 shared
Other insiders at the same companies
- Matthew W. DavisAQST
- Richard J DalyAQST
- Daniel BarberAQST
- Sherry KorczynskiAQST
- Peter E. BoydAQST
- Cassie JungAQST
- Julie KropAQST
- Timothy E MorrisAQST
- Abigail L. JenkinsAQST
- Gregory B BrownAQST
- Marco TagliettiAQST
- Thomas A. ZalewskiAQST
- Melina CioffiAQST
- Lori J BraenderAQST
- A Ernest Toth JrAQST
- Matthew J. GreenhawtAQST
Questions about John Cochran
- What is John Cochran's role at Aquestive Therapeutics, Inc.?
- John Cochran reports to the SEC as director at Aquestive Therapeutics, Inc. (AQST), according to the latest filing on June 12, 2026.
- How many shares does John Cochran own?
- After the latest filing that states it, John Cochran directly owned 99,486 shares of Aquestive Therapeutics, Inc. (AQST). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has John Cochran bought or sold stock recently?
- No open-market purchases or sales by John Cochran are on file. The filings report grant or award and other acquisition or disposition.
- How do I get alerts when John Cochran files?
- Follow John Cochran on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by John Cochran (SEC CIK 0001406773). Totals count each trade once, skipping amendments whose original is on file, from Mar 17, 2021 on. View on SEC EDGAR · Get this as JSON